Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
about
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
description
clinical trial
@en
klinisch onderzoek
@nl
name
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
@en
type
label
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
@en
prefLabel
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
@en
P6153
P1476
Phase 3, Randomized, Double-Bl ...... Long Term Follow-Up (CARE-PWS)
@en
P1813
CARE-PWS
@en
P3098
NCT03649477
P4844
P580
2018-11-20T00:00:00Z
P582
2019-12-01T00:00:00Z